Monday , November 18 2019
Home / canada / John Jones was licensed for one fight to participate in UFC 235 after a lengthy hearing by NAC.

John Jones was licensed for one fight to participate in UFC 235 after a lengthy hearing by NAC.



John Jones will really fight at UFC 235.

The current UFC light heavyweight champion received a license for one fight to compete on March 2 against Anthony Smith in the main UFC 235 tournament on Tuesday afternoon at the hearing of the Nevada Athletic Commission (NAC). At a long meeting that lasted more than three hours, NAC officials determined that Jones would have to undergo drug testing at least twice a month until UFC 235, and then continue to follow the same strict testing schedule for the whole 2019 if he wishes fight again in Nevada.

Jones will have to pay for additional drug tests in the run-up to UFC 235.

“It's on you,” said Jones Commissioner Anthony Marnell. “It's on your shoulders. I like what I hear, I like what I see, but the evidence is in pudding. Therefore, I am glad that you have returned here, you will always be treated with respect, and I wanted to make sure that you understood it today. Welcome back to Nevada and do the right thing from now on. As you know, we will often visit you. ”

In the second half of 2018, Jones tested positive for the presence of trace amounts of a long-term metabolite of oral turinabol. As a result of screening USADA preparations, out of competition, held on August 9, eight picograms of a long-term metabolite in Jones were detected. the system is the first disclosed example of such a result for Jones since his unsuccessful drug test in 2017. A subsequent USADA drug test on September 18 also gave a positive result for 19 picograms of the same long-term metabolite. Then Jones gave a negative result in four consecutive drug tests – September 21, October 2, November 11 and 14 – before the long-term metabolite reappeared in the range from 60 to 80 picograms in the out-of-competition race. The USADA test was conducted on December 9th.

The drug test on December 9 was the catalyst for the UFC, uprooting his show on December 29, UFC 232, from Nevada to California just six days before the event. Due to lack of time to review the Jones case or hold a hearing in connection with the festive season, the Nevada Sports Commission was not ready to grant Jones a license to participate in UFC 232.

However, because of her acquaintance with the Jones case, the California State Sports Commission (CSAC) was ready to license Jones as soon as possible for UFC 232. Under the terms of the CSAC, Jones needed a light heavyweight champion to agree to participate in the competition. Sign up for additional drug testing at the Voluntary Anti-Doping Agency (VADA). Jones then tested positive for a 33 picogram of the same long-term oral metabolite of Turinabol during a screening on December 28th conducted by VADA on the day of weighing.

In all four cases of positive tests, USADA and CSAC agreed that Jones was not responsible for dirty results. Instead, both organizations concluded that the presence of a long-term oral metabolite of turinabol was actually a “pulsating” residue of the same substance that caused Jones to serve a 15-month suspension due to his unsuccessful UFC 214 drug test in July 2017 . Thus, both organizations agreed that Jones would be allowed to compete in UFC 232, citing the logic of “double danger”, similar to the logic that does not allow US citizens to be charged with criminal cases for the same crime twice.

At a lengthy hearing on Tuesday, the testimony of USADA Senior Director for Results Management and Investigation Jeff Cook, Director of Science of USADA Matthew Fedoruk and Dr. Daniel Eichner, Executive Director of Salt Lake City Research and Testing for Sports Medicine in Salt Lake City, whose previous testimony was heard. led to the fact that the CSAC allowed Jones to fight at UFC 232. All three answered numerous questions concerning the science underlying the Jones case and the processing of its results, and repeated several times that modern science cannot accurately determine the exact time frame as to how long the long-term metabolite M3 of oral turinabol can be detected in the athlete’s body.

Commissioner Marnell began the trial, calling Jones's situation an “anomaly” that he had never seen before. He explained that the decision of NAC to allow California to move ahead with Jones on UFC 232 as soon as possible was a decision based on conscience rather than regulation, and that in any other specific situation “your career will be over. Commissioner Chris Olt added that Jones' case "drove our asses right into the corner."

During the meeting, Marnell expressed concern that the Jones case would not be used as a kind of card without imprisonment for other fighters in the future, and encouraged all parties involved to work on more consistent and rigorous testing to learn more about jones system. At some point, Eichner noted that other substances were found to have the same “pulsating” effect as the M3 metabolite, including the anti-estrogenic agent clomiphene, which ironically showed a positive result for 2016.

It is noteworthy that several NAC commissioners opposed Cook because the USADA considered the case and failed to disclose the numerous unfavorable results of Jones’s tests at the licensing hearings held by the CSAC before December 11 in Los Angeles for UFC 232. In one of the most ardent exchanges On the same day, Marnell called the statements of USADA on this subject “weak and soft.”

The NAC Commissioner also expressed his opinion on the 10-month interval from October 2017 to August 2018, in which Usada Jones underwent a zero drug test, despite everything that surrounded him. Cook retroactively agreed that testing during this period could provide useful data for the commission and USADA to weigh the current Jones case.

In the end, Jones defeated Gustfasson in the third round by technical knockout at the Forum in Inglewood on December 29 to regain the light heavyweight title in the main UFC 232 tournament. He passed numerous drug tests at night conducted by USADA and CSAC.

Johns, 31, is a multiple offender when it comes to drug testing. The Bones had previously been serving a one-year suspension for an unsuccessful drug test in connection with his unsuccessful rematch with UFC 200 against Daniel Cormier in July 2016. Competition Usada. The unsuccessful test ended up knocking him out of a duel with Cormyer in the main tournament just a few days before the release of UFC 200.

Jones (23-1, 1 NC) never really lost in an MMA cage. The only career loss of the two-time UFC light heavyweight champion was due to disqualification in the scandalous fight of 2009 against Matt Hamill, which Jones won dexterously. Jones' resume at Octagon includes victories over many world-class fighters and former champions such as Gustafsson (x2), Ryan Bader, Mauricio Rua, Quinton Jackson, Glover Teixeira, Vitor Belfort and Rashad Evans, among others.

Jones is expected to attend a press conference in Las Vegas on Thursday, January 31st, in connection with his latest problems in the work of the commission.


Source link